WO2004031234A3 - Regulation of human calcium-independent alpha-latrotoxin receptor - Google Patents

Regulation of human calcium-independent alpha-latrotoxin receptor Download PDF

Info

Publication number
WO2004031234A3
WO2004031234A3 PCT/EP2003/011058 EP0311058W WO2004031234A3 WO 2004031234 A3 WO2004031234 A3 WO 2004031234A3 EP 0311058 W EP0311058 W EP 0311058W WO 2004031234 A3 WO2004031234 A3 WO 2004031234A3
Authority
WO
WIPO (PCT)
Prior art keywords
human calcium
regulation
independent alpha
latrotoxin receptor
latrotoxin
Prior art date
Application number
PCT/EP2003/011058
Other languages
French (fr)
Other versions
WO2004031234A2 (en
Inventor
Alex Smolyar
Original Assignee
Bayer Healthcare Ag
Alex Smolyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag, Alex Smolyar filed Critical Bayer Healthcare Ag
Priority to AU2003291985A priority Critical patent/AU2003291985A1/en
Publication of WO2004031234A2 publication Critical patent/WO2004031234A2/en
Publication of WO2004031234A3 publication Critical patent/WO2004031234A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Reagents that regulate human calcium-independent alpha-latrotoxin receptor and reagents which bind to human calcium-independent alpha-latrotoxin receptor gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cardiovascular disorders, CNS disorders, diabetes, and obesity.
PCT/EP2003/011058 2002-10-07 2003-10-07 Regulation of human calcium-independent alpha-latrotoxin receptor WO2004031234A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003291985A AU2003291985A1 (en) 2002-10-07 2003-10-07 Regulation of human calcium-independent alpha-latrotoxin receptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41626602P 2002-10-07 2002-10-07
US60/416,266 2002-10-07

Publications (2)

Publication Number Publication Date
WO2004031234A2 WO2004031234A2 (en) 2004-04-15
WO2004031234A3 true WO2004031234A3 (en) 2004-08-19

Family

ID=32069943

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/011058 WO2004031234A2 (en) 2002-10-07 2003-10-07 Regulation of human calcium-independent alpha-latrotoxin receptor

Country Status (2)

Country Link
AU (1) AU2003291985A1 (en)
WO (1) WO2004031234A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045111A1 (en) * 1998-03-04 1999-09-10 Icos Corporation Lectomedin materials and methods
WO2000005264A1 (en) * 1998-07-23 2000-02-03 Takeda Chemical Industries, Ltd. Novel g protein-conjugated receptor protein and dna thereof
WO2000052039A2 (en) * 1999-03-04 2000-09-08 Icos Corporation Lectomedin materials and methods
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045111A1 (en) * 1998-03-04 1999-09-10 Icos Corporation Lectomedin materials and methods
WO2000005264A1 (en) * 1998-07-23 2000-02-03 Takeda Chemical Industries, Ltd. Novel g protein-conjugated receptor protein and dna thereof
EP1103563A1 (en) * 1998-07-23 2001-05-30 Takeda Chemical Industries, Ltd. Novel g protein-conjugated receptor protein and dna thereof
WO2000052039A2 (en) * 1999-03-04 2000-09-08 Icos Corporation Lectomedin materials and methods
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EM_EST EMBL; 21 October 2001 (2001-10-21), "603178286F1 NIH_MGC_121 Homo sapiens cDNA clone IMAGE:5242533 5', mRNA sequence", XP002282523, retrieved from EBI Database accession no. BI916346 *
ICHTCHENKO K ET AL: "A NOVEL UBIQUITOUSLY EXPRESSED ALPHA-LATROTOXIN RECEPTOR IS A MEMBER OF THE CIRL FAMILY OF G-PROTEIN-COUPLED RECEPTORS", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 9, 26 February 1999 (1999-02-26), pages 5491 - 5498, XP000828192, ISSN: 0021-9258 *
MATSUSHITA H ET AL: "The latrophilin family: multiply spliced G protein-coupled receptors with differential tissue distribution", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 443, no. 3, 29 January 1999 (1999-01-29), pages 348 - 352, XP004259173, ISSN: 0014-5793 *

Also Published As

Publication number Publication date
WO2004031234A2 (en) 2004-04-15
AU2003291985A8 (en) 2004-04-23
AU2003291985A1 (en) 2004-04-23

Similar Documents

Publication Publication Date Title
WO2002059621A3 (en) Regulation of transthyretin to treat obesity
WO2002036754A3 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
WO2002072824A3 (en) Human transient receptor potential channel protein.
WO2004031234A3 (en) Regulation of human calcium-independent alpha-latrotoxin receptor
WO2004031375A3 (en) Regulation of human 3’, 5’ cyclic nucleotide phosphodiesterase pde1c
WO2004029086A3 (en) Regulation of human calcium-independent alpha-latrotoxin receptor homolog 3
WO2002036629A3 (en) Regulation of human serotonin receptor precursor
WO2001077149A3 (en) Regulation of human cyslt2-like gpcr protein
WO2002099106A3 (en) Regulation of human secretin -type gpcr
WO2002032938A3 (en) Regulation of human pgc-1-like protein
WO2003072767A3 (en) Regulation of human lipase
WO2002062974A3 (en) Regulation of human elongase hselo1-like protein
WO2002042435A3 (en) Regulation of human tyrosine phosphatase
WO2002031160A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002055710A3 (en) Regulation of human purple acid phosphatase
WO2003052088A3 (en) Regulation of human sialyltransferase
WO2003100087A3 (en) Regulation of novel human asparagine-hydroxylases
WO2002031161A3 (en) Regulation of human phospholipase-like enzyme
WO2002057461A3 (en) Regulation of human adam-ts-like zinc metalloprotease
WO2002099107A3 (en) Regulation of human trace amine receptor ta5
WO2002062975A3 (en) Regulation of human elongase hselo1-like protein
WO2002031162A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002046403A3 (en) Regulation of human patched-like protein
WO2002101043A3 (en) Regulation of human ta4 receptor
WO2002036613A3 (en) Regulation of human patched-like protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP